GEN - Genetic Engineering and Biotechnology News
Get the latest news and information on genetic engineering and biotechnology including analysis, features, webinars, podcasts, and more.
Top 10 RNA-Based Biopharmas - genengnews.com
Nov 17, 2021 · In GEN’s initial A-List published in 2018, the top five public companies generated a combined $1.536 billion in revenues for 2017 and the first three quarters of 2018.By contrast, the top five ...
Top 10 Biomedical Issues of the Next Decade
Feb 1, 2020 · Anti-GMO sentiment will flip as the world utterly fails to achieve control over climate change. With temperatures rising, droughts increasing, and the climate becoming more turbulent, genetically ...
Making History with the 1990 Gene Therapy Trial
Mar 10, 2016 · A key to the success of the 1990 trial, Dr. Blaese said, was figuring out how to get the corrected gene into patients. As a molecular hematologist, Dr. Anderson focused on placing the corrected ...
Top 10 Biopharma Takeover Targets of 2024
Feb 1, 2024 · Viewed simply by numbers of merger and acquisition (M&A) deals, 2023 was a down year: 1,078 biotech companies found buyers last year, down from 1,088 in 2022, while the number of pharma companies ...
Progeria's Cardiovascular Complications Could Be Treated …
Oct 18, 2024 · The new findings are “highly promising,” suggested biological sciences PhD student Sahar Vakili. “This could pave the way for new treatments targeting cardiovascular complications in HGPS ...
Top 10 Publicly Owned Gene Editing Therapy Companies
May 31, 2024 · But at prices exceeding $1 million, gene editing therapies have been administered to only 250 people. Institutions working to raise that number include the companies in this A-List, which ...
Wave Clinical Trial Shows First Successful RNA Editing in …
Oct 16, 2024 · Wave Life Sciences said today its alpha-1 antitrypsin deficiency (AATD) candidate WVE-006 succeeded in the first-ever clinical demonstration of RNA editing in humans by achieving positive proof-of ...
Pfizer Withdraws SCD Drug Oxbryta after EMA Discloses …
Sep 26, 2024 · In the Phase III GBT440-032 trial (also known as HOPE Kids 2; NCT04218084), data showed eight deaths occurring in patients dosed with Oxbryta compared with two patients dosed with placebo. GBT440 ...
Prenatal Gene Therapy via LNPs Shows Promise in Model …
Oct 25, 2024 · Previously, Wang, Murthy, and colleagues reported that they had engineered rapidly hydrolysable LNPs (RD-LNPs). In a Nature Nanotechnology paper titled, “Acid-degradable lipid nanoparticles ...